SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFIs prolonged selloff is driving discussion, with traders blaming past dilutive share offerings, insider selling, short pressure, and a rate-sensitive market; some also fault managements silence as the stock weakens despite perceived business growth. The bearish frustration is countered by dip-buying and long-term optimism, while claims of coordinated manipulation remain speculation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

New 24-month HOPE-3 extension data for deramiocel, showing slower upper-limb decline after patients switched from placebo, is driving attention ahead of the FDAs review. Many traders see the findings as supportive of approval, while others question whether they resolve the FDAs statistical concerns; short-squeeze claims remain speculation.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, reflecting stronger demand for Amtagvi and Proleukin, drove the sharp move and drew analyst upgrades. Traders are broadly bullish and speculate about short covering, while others caution that the rally may be overextended and raise concerns about profit-taking or potential dilution; upcoming lung-cancer data is also in focus.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snaps SPECS AR-glasses presentation, AI features and enterprise partnerships with Nvidia, AWS and Salesforce are driving discussion, with bulls praising the technology and potential business uses. Skeptics question the glasses price, design and commercial demand, and many are frustrated that the enthusiasm has not translated into sustained gains.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings selection to develop the Navys next-generation F/A-XX fighter is driving attention, with traders highlighting its defense-business prospects and its position on both U.S. sixth-generation fighter programs. Some see the award as a meaningful boost, while skeptics say execution, free-cash-flow and commercial-program challenges remain.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is under pressure after a bearish Edgewater assessment raised concerns that growth and market-share gains may be stalling, with securities-class-action allegations adding to the debate. Bulls point to reported client expansion and e-commerce momentum as evidence the business remains strong, while skeptics cite competition and slowing growth.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is being tied to reported positive Phase 3 results for its personalized melanoma vaccine with Merck and anticipation of detailed data at the ESMO congress. Bulls see potential validation of its oncology platform and cite short-covering, while bears argue the market is pricing in uncertain future sales and broader cancer applications.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Boeings selection over Northrop Grumman for the Navys next-generation F/A-XX fighter program is drawing attention, with traders reacting to NOC losing the high-profile contract and linking it to the stocks weakness. Some view the pullback in the context of broader pressure on defense stocks.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

AMTM is drawing attention amid a persistent selloff and analyst downgrades, despite reported improvements in margins and earnings and a large contract backlog. Traders disagree over whether those strengths can offset weak revenue growth and a subdued outlook; repeated contract announcements have done little to ease frustration with the share price.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vandas positive Phase 3 Hetlioz results in delayed sleep-wake phase disorder are driving attention; the trial met its primary endpoint, and the company plans to discuss the data with the FDA before seeking an expanded indication. Traders welcomed the readout and potential new market, while some questioned the small study and whether the results will translate into commercial value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BitMine’s Ethereum Stack Crosses 6M, While Strategy Taps MSTR Sales To Buy BTC And STRC

Cryptocurrency

Crypto treasury Strive also bought 1,107 Bitcoin for about $94.5 million and now holds roughly 27,462 BTC.


MSTR, ASST Stocks Slide With Bitcoin: Strategy Proposes Daily Dividends, Matt Cole Challenges MSCI Rules 

Strategy proposed daily dividend accruals for STRF, STRC, STRK and STRD, with payments made on the next business day.


Strive CEO Says Tokenized Stocks Won't Impact Bitcoin Treasury Companies - People Are Here For The ‘Premium’

Equity

Strive’s Cole said some treasury companies launched with bad debt terms and will not survive.

MSTR Purchases Bitcoin After 2-Week Pause, Keeps Buying Back STRC: BMNR, ASST Keep Adding To Their Crypto Treasuries

Michael Saylor’s Strategy repurchased 1.77 million STRC shares for $174 million, taking its combined Bitcoin and STRC spend to nearly $250 million for the week.


Trump-Xi Meeting, SEC Tokenization Rule Seen As Near-Term Catalysts for Crypto Stocks, B. Riley Says

B. Riley raised its price targets on six crypto-linked stocks, including Strategy, SharpLink Gaming, Bitmine Immersion Technologies and Strive.


Bitcoin Nears $85K, MSTR, ASST Stocks Rally As Crypto Bulls Return Amid Easing Oil Prices 

The broader crypto market rose about 4% to just below $3 trillion, with XRP, SOL and ETH outperforming Bitcoin.


REX Shares Launches ASSX, T-REX 2X Long ETF on Strive (ASST)

REX Shares ("REX") and Tuttle Capital Management ("TCM") today announce the launch of the T-REX 2X Long ASST Daily Target ETF (Cboe: ASSX), a leveraged ETF providing 2x daily long exposure to Strive, Inc. (Nasdaq: ASST). ASSX is now listed and trading on Cboe. Fund name T-REX 2X Long ASST Daily...

CLARITY Act Hits A Senate Wall: Crypto CEOs Furious, Senators Defend ‘No’ Votes — Some Analysts Say Fight Isn't Over

While top leaders of cryptocurrency and fintech firms are disappointed that the Senate failed to pass the CLARITY Act, U.S. Senators who voted against the bill have their own reasons.

Bitcoin Slides, Crypto Stocks Decline As Trump-Backed CLARITY Act Fails To Pass Senate Vote 

Bitcoin and crypto-related stocks fell sharply on Tuesday after the Senate failed to advance the CLARITY Act.

The Smallest Bitcoin Treasury Stock Saw A Bigger August Than Strategy — While GME Sits Out

ASST stock has nearly doubled so far this month, while MSTR shares have gained around 30%. 


Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Extremely Bearish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$1.61	--	--	N/A
Q2 '26	-$0.95	-$3.65	-284.21%	MISSED
Q1 '26	-$2.69	-$4.53	-68.09%	MISSED
Q4 '25	-$0.20	--	--	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

ASST Earnings

Upcoming Earnings: Q3 '26

Historical Earnings